What should I do if I develop a rash while taking Buspar (buspirone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Discontinue Buspar and Contact Your Prescriber Immediately

If you develop a rash while taking Buspar (buspirone), you should stop the medication immediately and contact your healthcare provider. While rash is a known adverse effect occurring in approximately 1% of patients taking buspirone 1, any new rash requires prompt medical evaluation to rule out serious hypersensitivity reactions.

Why This Matters

Rash with buspirone can represent:

  • Simple drug reaction (most common): Mild, self-limited skin reaction that resolves after discontinuation
  • Serious hypersensitivity: Though rare with buspirone, severe skin reactions like Stevens-Johnson syndrome or drug rash with eosinophilia and systemic symptoms (DRESS) can occur with various medications and require immediate recognition 2

The FDA drug label specifically lists skin rash as an adverse event occurring in 1% of buspirone-treated patients in controlled trials 1. While this is relatively uncommon, the appearance of any rash warrants medication discontinuation until proper evaluation.

Immediate Actions

  1. Stop buspirone immediately - Do not take another dose
  2. Contact your prescriber - Same day notification is appropriate
  3. Document the rash - Note when it started, location, appearance, and any associated symptoms
  4. Monitor for warning signs of serious reactions:
    • Fever or flu-like symptoms
    • Blistering or peeling skin
    • Mucosal involvement (mouth, eyes, genitals)
    • Facial swelling or difficulty breathing
    • Joint pain or muscle aches

What Your Provider Will Assess

Your healthcare provider needs to determine:

  • Timing: When did the rash appear relative to starting buspirone?
  • Characteristics: Is it localized or widespread? Flat or raised? Itchy or painful?
  • Systemic symptoms: Any fever, malaise, lymph node swelling, or organ involvement?
  • Other medications: Could another drug be responsible?
  • Alternative causes: Contact dermatitis, viral illness, or other dermatologic conditions?

Treatment Approach

For mild, localized rash 1:

  • Discontinue buspirone
  • Symptomatic treatment with antihistamines (e.g., diphenhydramine 25-50 mg or cetirizine 10 mg)
  • Topical corticosteroids (moderate to high potency) if pruritic
  • Monitor for resolution over 1-2 weeks

For severe or progressive rash:

  • Immediate medical evaluation
  • Consider emergency department if blistering, mucosal involvement, or systemic symptoms present
  • May require systemic corticosteroids if hypersensitivity reaction confirmed

Important Caveats

  • Do not rechallenge: Once a drug-related rash occurs, do not restart buspirone without explicit guidance from your prescriber
  • Cross-reactivity is unlikely: Buspirone is structurally distinct from benzodiazepines and other anxiolytics, so alternative anxiety treatments remain available 1
  • Document the allergy: Ensure this reaction is recorded in your medical record to prevent future exposure

Alternative Anxiety Management

While buspirone is discontinued, discuss with your provider:

  • SSRIs/SNRIs: First-line pharmacologic options for generalized anxiety disorder 2
  • Cognitive behavioral therapy: Evidence-based non-pharmacologic treatment
  • Other anxiolytics: Depending on your specific anxiety disorder and medical history
  • Short-term symptom management: If needed while transitioning to alternative therapy

The key principle is that any new rash during medication therapy requires immediate evaluation and typically warrants drug discontinuation until causality can be established. With buspirone's relatively benign side effect profile overall 3, 4, the appearance of rash is notable and should not be ignored.

References

Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

Research

Review of the side-effect profile of buspirone.

The American journal of medicine, 1986

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.